HK1026096A1 - Novel triptolide derivatives useful in the treatment of autoimmune diseases - Google Patents

Novel triptolide derivatives useful in the treatment of autoimmune diseases

Info

Publication number
HK1026096A1
HK1026096A1 HK00105108A HK00105108A HK1026096A1 HK 1026096 A1 HK1026096 A1 HK 1026096A1 HK 00105108 A HK00105108 A HK 00105108A HK 00105108 A HK00105108 A HK 00105108A HK 1026096 A1 HK1026096 A1 HK 1026096A1
Authority
HK
Hong Kong
Prior art keywords
treatment
autoimmune diseases
derivatives useful
triptolide derivatives
novel triptolide
Prior art date
Application number
HK00105108A
Other languages
English (en)
Inventor
Michael J Jung
Mahinda Wickramaratne
Michael Hepperle
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of HK1026096A1 publication Critical patent/HK1026096A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK00105108A 1997-05-23 2000-08-16 Novel triptolide derivatives useful in the treatment of autoimmune diseases HK1026096A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86248897A 1997-05-23 1997-05-23
PCT/US1998/008470 WO1998052951A1 (en) 1997-05-23 1998-04-27 Novel triptolide derivatives useful in the treatment of autoimmune diseases

Publications (1)

Publication Number Publication Date
HK1026096A1 true HK1026096A1 (en) 2000-12-01

Family

ID=25338616

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00105108A HK1026096A1 (en) 1997-05-23 2000-08-16 Novel triptolide derivatives useful in the treatment of autoimmune diseases

Country Status (21)

Country Link
EP (1) EP0983275B1 (xx)
JP (1) JP2001525851A (xx)
KR (1) KR20010012822A (xx)
CN (1) CN1257507A (xx)
AR (1) AR012723A1 (xx)
AT (1) ATE222910T1 (xx)
AU (1) AU741917B2 (xx)
BR (1) BR9809678A (xx)
CA (1) CA2287977A1 (xx)
DE (1) DE69807466T2 (xx)
DK (1) DK0983275T3 (xx)
ES (1) ES2178207T3 (xx)
HK (1) HK1026096A1 (xx)
HU (1) HUP0003398A3 (xx)
IL (1) IL133088A0 (xx)
NO (1) NO995723L (xx)
NZ (1) NZ500762A (xx)
PT (1) PT983275E (xx)
TW (1) TW434235B (xx)
WO (1) WO1998052951A1 (xx)
ZA (1) ZA984174B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329148B1 (en) 1999-02-16 2001-12-11 The Board Of Trustees Of The Leland Stanford University Combined therapy of diterpenoid triepoxides and death domain receptor ligands for synergistic killing of tumor cells
US6569893B2 (en) * 2001-03-15 2003-05-27 Pharmagenesis, Inc. Amino acid derivatives of triptolide compounds as immune modulators and anticancer agents
US7847109B2 (en) 2002-05-31 2010-12-07 Pharmagenesis, Inc. Triptolide derivatives for modulation of apoptosis and immunosuppression
CN100398544C (zh) * 2002-09-18 2008-07-02 成都达远药物有限公司 高免疫抑制活性的水溶性雷公藤内酯醇衍生物及其应用
CN1726025A (zh) * 2002-12-17 2006-01-25 泛华医药公司 作为免疫调节剂和抗癌剂的雷公藤内酯醇衍生物
CN1223595C (zh) 2002-12-27 2005-10-19 中国科学院上海药物研究所 雷公藤内酯醇衍生物及其应用
US6943259B2 (en) * 2003-02-25 2005-09-13 Pharmagenesis, Inc. Halogenated triptolide derivatives as immunomodulators and anticancer agents
US7820834B2 (en) 2003-12-24 2010-10-26 Pharmagenesis, Inc. Triptolide 5,6-derivatives as immunomodulators and anticancer agents
US8048914B2 (en) 2004-02-09 2011-11-01 Pharmagenesis, Inc. Methods for isolation of triptolide compounds from Tripterygium wilfordii
DK1732536T3 (da) 2004-03-02 2012-06-25 Pharmagenesis Inc Tripolidlactonringderivater som immunomodulatorer og anticancermidler
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
US8617906B2 (en) 2004-10-13 2013-12-31 Pharmagenesis, Inc. Identification and screening of triptolide target molecules
CN102307881B (zh) * 2009-02-05 2014-12-24 药物起源公司 作为抗癌药和免疫调制剂的雷公藤内酯 c-环衍生物
AU2015413013B2 (en) * 2015-10-29 2020-11-05 Hangzhou Weben Pharmaceuticals Inc C14-hydroxyl esterified amino acid derivatives of triptolide, and preparation method and use thereof
CN114716503B (zh) * 2022-03-23 2024-03-12 广东省中医院(广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院) 一种雷公藤氯内酯醇的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005108A (en) * 1973-04-03 1977-01-25 Research Corporation Novel anti-leukemic diterpenoid triepoxides
US5430054A (en) * 1989-12-22 1995-07-04 Jiangsu Family Planning Institute Preparation methods of diterpene lactone compounds and application of the same to antifertility
US5663335A (en) * 1996-03-01 1997-09-02 Pharmagenesis, Inc. Immunosuppressive compounds and methods

Also Published As

Publication number Publication date
KR20010012822A (ko) 2001-02-26
HUP0003398A2 (en) 2001-03-28
HUP0003398A3 (en) 2001-09-28
WO1998052951A1 (en) 1998-11-26
DE69807466T2 (de) 2003-04-24
AU741917B2 (en) 2001-12-13
CN1257507A (zh) 2000-06-21
DE69807466D1 (de) 2002-10-02
JP2001525851A (ja) 2001-12-11
NZ500762A (en) 2001-08-31
EP0983275A1 (en) 2000-03-08
CA2287977A1 (en) 1998-11-26
AU7260798A (en) 1998-12-11
ZA984174B (en) 1998-11-23
EP0983275B1 (en) 2002-08-28
PT983275E (pt) 2003-01-31
IL133088A0 (en) 2001-03-19
DK0983275T3 (da) 2002-12-23
NO995723D0 (no) 1999-11-22
BR9809678A (pt) 2000-07-11
ATE222910T1 (de) 2002-09-15
TW434235B (en) 2001-05-16
NO995723L (no) 2000-01-21
ES2178207T3 (es) 2002-12-16
AR012723A1 (es) 2000-11-08

Similar Documents

Publication Publication Date Title
ZA983452B (en) Substituted pyrrolopyridines useful in the treatment of inflammatory diseases.
IL132318A0 (en) Substituted imidazoles useful in the treatment of inflammatory diseases
PL348059A1 (en) Compounds useful in the treatment of inflammatory diseases
GB9701206D0 (en) Serine derivatives and their use as therapeutic agents
PL328822A1 (en) Human bikinine
AP9701029A0 (en) Indole derivatives useful in the treatment of osteoporosis
HK1026096A1 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
ZA984177B (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
PL336579A1 (en) Treatment of diseases associated with cytokinins
EP0797440A4 (en) TREATING AUTOIMMUNE DISEASES WITH THE AID OF 2-AMINOPURINE DERIVATIVES
GB9620777D0 (en) Therapeutic use
IL129622A0 (en) Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
IL129618A0 (en) Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
SI0983275T1 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
GB9726223D0 (en) The treatment of materials
IL129626A0 (en) Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
GB2286716B (en) The treatment of solid wastes
ZA977005B (en) Therapeutic uses
ZA953839B (en) The administration of magnesium
IL129617A0 (en) Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
AUPO922297A0 (en) Disulphide useful in the treatment of cardiovascular diseases
ZA984823B (en) Pyrrolo(2,1,5-cd)indolizine derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ZA984822B (en) Pyrrolo (2,11,5-cd) indolizine derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120427